Latest Australian Government News

Caravel Minerals has taken a major step forward by securing a preliminary grid connection offer from Western Power, paving the way for reliable, low-cost power at its Caravel Copper Project.

Buxton Resources has reported compelling partial leach assay results from its Centurion Project drillhole CN002DD, revealing high silver concentrations alongside elevated base metals, suggesting promising nearby mineralisation.

Betashares Capital Ltd has released updated final distribution amounts for its suite of ETFs for the September 2025 period, including estimated franked percentages for select funds.

Papyrus Australia has appointed Daniel Schmidt as CEO and secured a $250k government grant alongside a binding agreement to produce biodegradable mining products, marking a decisive shift from R&D to commercial operations.

Australian Vanadium Limited has locked in a US$10 million secured loan from major shareholder RCF to advance its flagship vanadium project and prepare for a significant government battery storage tender.

Vanguard Investments Australia has announced estimated distribution amounts for 20 of its ETFs, with payments scheduled for mid-October 2025. Investors can expect detailed income figures across Australian and international equity and fixed income funds.

Lunnon Metals has reported promising drilling results at its Plentiful gold prospect, extending the mineralised structure to over 450 metres and revealing consistent widths and modest gold grades. These findings enhance the scale of opportunities within its Kambalda Gold & Nickel Project.

Recce Pharmaceuticals has initiated patient dosing in its pivotal Phase 3 trial for diabetic foot infections in Indonesia, targeting a significant market with high diabetes prevalence. Interim results expected in early 2026 could accelerate regulatory approval and commercial launch.

Micro-X Ltd has secured a $4.4 million Australian Government grant to develop and trial a portable Head CT scanner designed for standard ambulances, aiming to transform emergency stroke care with faster diagnosis and treatment.

Regis Healthcare reveals a funding update amid government changes, projecting modest EBITDA growth despite a funding gap and rising wage costs.

Morella Corporation has identified 12 new high-priority lithium exploration targets at its Mallina project in Western Australia through a detailed ground gravity survey, setting the stage for further drilling and sampling.

Neurizon Therapeutics has locked in a significant R&D tax incentive advance covering overseas and domestic development costs for its lead ALS drug candidate NUZ-001, accelerating its clinical progress with a $5.6 million rebate expected in 2025.